Corteva has revealed the corn innovation pipeline for Vylor, its advanced seed and genetics business set to separate on October 1, 2026. The company announced plans to launch seven new corn technology platforms through 2035, targeting more than $2 billion in incremental revenue.
The centerpiece of Vylor’s strategy is what the company calls the industry’s first trait designed to improve yield and yield stability. Field trials across the Americas showed the trait delivered an average of three additional bushels per acre, with gains reaching up to 10 bushels per acre in some cases.
“Corn is already one of the most planted crops in the world and its importance will only continue to grow,” said Sam Eathington, chief technology officer of the future Vylor. “Our pipeline changes the game through 2035.”
The rollout begins in 2028 with Abranvo technology launching in Latin America. The platform provides fall army worm control using two new modes of action, combined with yield stability improvements and herbicide tolerance options.
North America will see its first launches in 2029, featuring next-generation above-ground insect control paired with the proprietary yield trait. Later launches include gene-edited, multi-disease resistant (MDR) corn that combats four separate diseases: Northern Corn Leaf Blight, Grey Leafspot, Southern Rust and Anthracnose Stalk Rot.
By 2031, Vylor plans to introduce below-ground insect control technology in North America with two new, non-Bt modes of action for corn rootworm, including what the company describes as the industry’s first plant-based option.
These new platforms will be deployed across 90% of Vylor’s corn business and made available through multiple routes to market, including licensing agreements.
Vylor’s strategy centers on three priorities: investing in technology that delivers farmer value, leveraging elite germplasm to expand brand strength, and developing proprietary biotech platforms that position the company as a licensor rather than licensee.
The company said the pipeline represents billions of dollars invested over the past decade and builds on more than 100 years of genetics and breeding experience.
